Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production by Leema, George et al.
Keratitis due to Aspergillus flavus: Clinical profile, molecular
identification of fungal strains and detection of aflatoxin
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Purpose: To document the clinical profile of patients with keratitis due to Aspergillus flavus and to elaborate on differences
in the aflatoxin-producing potential of keratitis strains versus environmental strains of A. flavus.
Methods: Over a 6-month period, strains of Aspergillus flavus were isolated in culture from corneal scrape or biopsy
material of patients who presented with suppurative keratitis (clinical isolates). The strains were confirmed to be A. flavus
by molecular methods (amplification of the internal transcribed spacer 2 [ITS 2] region and direct sequencing followed
by comparative GenBank analysis). The aflatoxin-producing potential of each strain was determined by thin-layer
chromatography. The ability of each strain to form sclerotia in Czapek-Dox agar (CDA) after 7 days incubation at 30 °C
in the dark and to produce a beige ring in yeast extract sucrose agar supplemented with methyl β-cyclodextrin and sodium
desoxycholate (YESD medium) after 3 days incubation at 30 °C was also assessed. For comparison, the tests were also
run on 10 strains of A. flavus (identity confirmed by molecular methods) collected from local farming areas (environmental
isolates).
Results: Aflatoxin B1 was detected in 16 (80%) of 20 culture filtrate or mycelial homogenate samples of the clinical
isolates (mean concentration: 366.7±125.4 parts per billion [ppb]) but in only eight (40%) of 20 samples of environmental
isolates (mean concentration: 306.6±125.4 ppb). Seven of the eight aflatoxin-producing clinical isolates and two of the
four aflatoxin-producing environmental isolates formed sclerotia (>400 μm) and a beige ring in culture.
Conclusions: Aflatoxin B1 was detected in a significantly higher percentage of growth samples of clinical isolates (80%)
than growth samples of environmental isolates (40%) (χ2=6.667; p=0.0098); the therapeutic implications of this finding
require further study. The production of sclerotia and a beige ring in culture appear to be useful markers of aflatoxin-
producing potential in strains of A. flavus isolated from keratitis.
Aspergillus flavus is the name now used to describe a
species  as  well  as  a  group  of  closely  related  species  of
aspergilli [1]. A. flavus is second only to Aspergillus fumigatus
as a cause of human invasive and non-invasive aspergillosis
[2-4]. A. flavus is also an important cause of keratitis [5] and
is reported in some studies to be the most frequent Aspergillus
species causing keratitis [6-8].
A. flavus is able to produce potent mycotoxins, known as
aflatoxins that are potentially harmful to humans and animals.
Of the aflatoxins, aflatoxin B1 is particularly important, since
it is the most toxic and potent hepatocarcinogenic natural
compound ever characterized [9]. The ability of strains of A.
flavus to produce aflatoxins is reported to be highly variable;
several strains are non-toxigenic because aflatoxin synthesis
may  become  unstable  in  these  fungi  [10].  Moreover,  the
production  of  aflatoxins  is  influenced  by  various
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environmental conditions such as temperature [11-13], pH
[14-16], and nutrient sources [17-19].
Aflatoxins are known to be acutely and chronically toxic
to animals, including humans, and can cause acute damage to,
or  cirrhosis  of,  the  liver,  induce  tumors  and  produce
teratogenic effects [20,21]. Interestingly aflatoxin B1 and/or
its metabolites appear to localize in the melanin pigment of
the eye, according to observations made in the eyes of mice
[22,23], cows [23], rainbow trout fish [24] and sheep [25]
following the administration of radiolabelled aflatoxin B1 by
various routes; localization of radiolabelled aflatoxin B1 in
the vitreous [24] and the palpebral and bulbar conjunctiva
[25,26] have also been noted. When aflatoxin B1 was injected
into  chick  embryos,  anophthalmia  was  one  of  the
malformations noted [27]. Specific toxic effects of aflatoxins
in  the  cornea  were  demonstrated  in  chicks  that  had  been
administered  aflatoxin  orally;  haziness  of  the  cornea  and
separation of corneal lamellae, in addition to infiltration by
polymorphonuclear leucocytes, were observed [28].
Although A. flavus is an important cause of keratitis, and
aflatoxins are known to be produced by A. flavus, there is a
paucity of data regarding possible aflatoxin production by A.
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843flavus strains isolated from patients with keratitis. However,
the results of one unpublished study (M. Saraswathy, 2006,
PhD thesis, Bharathidasan University, Tiruchirapalli, India)
suggested that aflatoxin production occurred more frequently
in isolates of A. flavus from patients with keratitis than it did
in isolates of A. flavus from the environment. These findings
are interesting since filamentous fungi causing keratitis, such
as  species  of  Aspergillus  and  Fusarium,  are  known  to
ultimately originate from the environment.
In the present report, the clinical profile of a series of
patients  with  culture-proven  A.  flavus  keratitis  is  briefly
documented. Molecular methods were used to confirm the
identity  of  the  fungal  strains  isolated  as  A.  flavus.  More
importantly, the potential of the keratitis A. flavus strains to
form  aflatoxin,  and  associated  markers  of  aflatoxin
production,  in  culture  has  been  compared  with  similar
potential of A. flavus strains isolated from the environment.
METHODS
Patients and clinical strains of fungi: Over a 6-month period
(May  to  October  2008),  178  patients  with  suppurative
Figure  1.  Photomicrograph  showing  a  septate,  branching  hypha
(arrow) of Aspergillus flavus in corneal scrape material from a patient
with keratitis (Gram stain; 1,000×). Direct microscopic examination
of corneal material by the method of Gram staining revealed the
presence of fungal hyphae.
(suspected microbial) keratitis underwent standard clinical
and  microbiological  investigations  [29]  at  the  Institute  of
Ophthalmology,  Joseph  Eye  Hospital,  Tiruchirapalli,
Tamilnadu State, India. Corneal scrape material was collected
from  all  the  patients  for  microbiological  processing;
additionally, corneal biopsy material was collected from 15
patients. Written informed consent was obtained from each
patient before performing corneal scraping or corneal biopsy
procedures  to  obtain  samples  for  microbiological
investigation. The study was approved by the Institutional
Review Board of Institute of Ophthalmology, Joseph Eye
Hospital, Tiruchirappalli, Tamil Nadu. Filamentous fungi (55
strains) were isolated from the corneal material in 55 patients.
These fungal isolates were deemed to be significant (and not
mere environmental contaminants) because they were isolated
on multiple culture media and because direct microscopic
examination  of  corneal  material  revealed  the  presence  of
fungal  hyphae  (Figure  1).  Ten  of  the  55  strains  were
provisionally identified as A. flavus based on macroscopic and
microscopic characteristics (see below).
Fungal strains: Environmental strains of filamentous fungi,
provisionally identified as A. flavus based on macroscopic and
microscopic  characteristics  (see  below),  were  isolated  on
plates of Sabouraud glucose neopeptone agar (SDA; HiMedia,
Mumbai, India) by a settle-plate technique [30] from farming
areas in and around Tiruchirappalli, India.Clinical strains of
A. flavus were isolated as described earlier.
Culture conditions: Soon after primary isolation, both clinical
and environmental strains were subcultured once onto SDA
or potato dextrose agar (PDA) slants and incubated at 25–
30 °C. After growth was obtained, they were stored at 4 °C
until analysis.
Identification  of  fungal  isolates:  Isolates  preliminarily
identified as A. flavus, based on macroscopic and microscopic
morphology on SDA and PDA, were subcultured to Czapek-
Dox agar (CDA). The identification of A. flavus was made
based  on  gross  colony  morphology  and  color  and  on
microscopic features (magnification of 100× and 400×) in
lactophenol cotton blue-stained wet mounts [1].
Molecular identification of fungal isolates:
DNA  Extraction—DNA  was  extracted  from  72  h-
cultures  of  the  isolates  grown  in  Sabouraud  glucose-
neopeptone broth, essentially as described by Kumar et al.
[31]. The cultures were centrifuged at 5000× g for 5 min, and
the resulting pellets were suspended in STES buffer (SDS-1%,
Tris HCl-0.2 mol/l, EDTA-0.01 mol/l, NaCl-0.5 mol/l,); glass
beads were then added in a 1:1 ratio, and rigorous vortexing
was  done  for  10  min.  The  cell  debris  was  removed  by
centrifugation  followed  by  extraction  with  phenol,
chloroform and isoamyl alcohol in a ratio of 25:24:1. To the
aqueous  phase,  100  µg  of  proteinase  K  were  added  and
incubated at 55 °C for 15 min, followed by extraction with a
0.5 volume of chloroform. DNA was precipitated with equal
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844volumes of ice-cold isopropyl alcohol, and the pellets were
washed with 70% ethanol and suspended in DNase/RNase-
free water. The purity of the DNA was checked using both
agarose  gel  electrophoresis  and  UV  spectrophotometric
analysis, that is, the A260/ A280 ratio.
DNA amplification—The ITS2 region of each test strain
was amplified using the primers ITS3: 5′-GCT CGA TGA
AGA ACG CAG C-3′ and ITS4: 5′-TCC TCC GCT TAT TGA
TAT GC-3′ [32]. The PCR reaction was performed with a total
reaction volume of 50 µl consisting of PCR buffer (1×), 0.2
mmol each of dATP, dGTP, dCTP, and dTTP, 0.5 µM of each
primer  and  1.5  µl  of  Taq  DNA  polymerase.  After  initial
denaturation at 95 °C for 15 min, 30 cycles of amplification
(denaturation at 95 °C for 30 s, annealing at 50 °C for 1 min
and extension at 72 °C for 1 min) and a final extension at 72 °C
for  2  min  were  performed  in  a  thermocycler  (Eppendorf,
Hamburg, Germany).
Purification  and  sequence  analysis—The  amplicons
were purified by Mini Elute gel extraction kit (Qiagen, Hilden,
Germany).  DNA  sequencing  was  performed  at  Genei
(Bangalore,  India).  The  sequencing  results  were  used  to
perform a) pairwise nucleotide sequence comparisons with 15
reference  Aspergillus  strains  and  b)  DNA  alignments  by
CLUSTALW. In addition, comparative GenBank sequence
analysis for the identification and differentiation of the species
of the study fungal strains was performed by an advanced,
non-gapped  BLAST  search  with  no  filtering  for  low
complexity. The 5.8S-ITS2- 28S gene complex sequences of
all the isolates were submitted to GenBank, and accession
numbers were provided (Table 1).
Assessment of aflatoxin production in culture: The presence
of  aflatoxin  was  sought  in  culture  filtrates  and  mycelial
homogenates of each clinical and environmental strain of A.
flavus. Each fungal strain was first subcultured onto slopes of
SDA and incubated at 25–30 °C for 72 h for growth and
sporulation. Conidia were harvested with physiologic saline
containing 0.04% Tween-80 and suspensions of conidia were
prepared to contain approximately 1×105 CFU/ml. One ml of
each conidial suspension was then inoculated into 150 ml of
sterile glucose-salt media [11] and incubated at 25–30 °C for
14 days.
Preparation of culture filtrates and mycelial homogenates:
To prepare culture filtrates, each 14-day-old broth culture was
successively filtered (Whatman No. 541 and Whatman No. 1
filter paper [Sigma Chemical Co., St. Louis , MO]) and then
centrifuged at 17,000× g for 30 min at 4 °C in a cooling
centrifuge (Heraeus, Hanau, Germany) to yield a supernatant
which was then filtered through a 0.45 μm pore size membrane
filter  (Millipore,  Bangalore,  India)  to  remove  any
contaminating material, including fungal conidia and bacteria.
To prepare mycelial homogenates, mycelial mats collected
from the 14-day-old broth cultures were ground intermittently
for 30 min with a small amount of sterile physiologic saline
using sterile ground glass in a mortar and pestle under ice-cold
conditions. The fully-ground material was then extracted with
sterile saline and centrifuged at 17,000× g for 30 min at 4 °C
to  remove  glass  and  particulate  matter;  the  resulting
supernatant was collected for analysis. The culture filtrates
and mycelial homogenates thus prepared were screened for
the presence of aflatoxin.
TABLE 1. ACCESSION NUMBERS FOR THE SEQUENCES OF THE CLINICAL AND ENVIRONMENTAL STRAINS OF ASPERGILLUS FLAVUS.
Sample number Isolate ID GenBank accession number
1 C1 HM003455
2 C2 HM003456
3 C3 HM003457
4 C4 HM003474
5 C5 HM003473
6 C6 HM003458
7 C7 HM003459
8 C8 HM003460
9 C9 HM003461
10 C10 HM003462
11 E1 HM003463
12 E2 HM003464
13 E3 HM003465
14 E4 HM003466
15 E5 HM003467
16 E6 HM003468
17 E7 HM003469
18 E8 HM003470
19 E9 HM003471
20 E10 HM003472
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846Screening for aflatoxin production: The presence of aflatoxin
in  each  culture  filtrate  and  mycelial  homogenate  was
determined  by  thin-layer  chromatography  (TLC)  using  a
standard method [33] with some modifications. Each culture
filtrate or mycelial homogenate was, in succession, extracted
with  acetone,  filtered  (Whatman  No.  1  [Sigma  Chemical
Co.]), extracted with chloroform in a separating funnel for 3
min, filtered, passed through anhydrous sodium sulfate and
concentrated at 60 °C to near dryness. The residue was re-
suspended in chloroform and spotted in duplicate on 20×20
cm  TLC  silica  gel  plates  (Merck,  Darmstadt,  Germany),
which  were  developed  in  chloroform:methanol  (98:2).
Aflatoxin spots were visualized under ultraviolet light at 365
nm. Standard aflatoxin B1 (Sigma Chemical Co., St. Louis,
MO) was used for comparison in each run. All experiments
were performed at least twice.
Quantification  of  aflatoxin:  Aflatoxin  detected  by  the
screening process was quantified by the method of Nabney
and Nesbitt [34]. The silica gel containing the aflatoxin band
was scraped off from the TLC plate and extracted with cold
methanol for 3 min. The methanol was then filtered off and
the silica gel was washed 5 times with fresh methanol, the
combined methanolic filtrate being brought up to 5 ml, and
the ultraviolet absorption spectrum of the methanolic solution
was then recorded. The difference between the optical density
of methanolic filtrate at 363 nm and that at 420 nm was
determined. This difference was then divided by the extinction
coefficient (19,800) of aflatoxin B1, and the resulting figure
was multiplied by the molecular weight of aflatoxin B1 (312)
to obtain the concentration of aflatoxin.
Determination of other characteristics in the fungal strains:
In addition to possible aflatoxin-producing potential, each
strain was tested for formation of sclerotia and production of
a beige ring in culture. To assess formation of sclerotia, 2 μl
of each conidial suspension (prepared as described earlier)
were inoculated at a single point at the center of Petri dishes
(90 mm) containing CDA and incubated at 30 °C for 7 days
in the dark. To assess formation of a beige ring, the conidial
suspensions  were  inoculated  onto  Petri  dishes  containing
yeast extract sucrose agar (2% yeast extract; 20% sucrose; 2%
agar) supplemented with methyl β-cyclodextrin (0.6%) and
sodium  desoxycholate  (0.3%)  (YESD  medium  [35],  and
incubated at 30 °C for 3 days in the dark.
Statistical  analysis:  The  difference  between  the  mean
aflatoxin  concentration  in  20  culture  filtrate  or  mycelial
homogenate samples of clinical strains and that in 20 similar
samples of environmental strains was analyzed by the Student
“t” test. The χ2 test [36] was applied wherever relevant to
analyze  the  statistical  significance  of  differences  in
proportions.
RESULTS
Salient information regarding the 10 patients with keratitis
from whom strains of A. flavus were isolated is provided in
Table 2. The two aflatoxin-nonproducing strains were isolated
from corneal material from the left eye in two males, while
the  eight  aflatoxin-producing  strains  were  isolated  from
corneal material from three males and five females (from the
left eye of four patients and the right eye of four patients).
Most of the corneal ulcers from which toxin-producing strains
were isolated tended to be moderate in size to total ulcers.
With reference to the outcome of keratitis in two patients from
whom toxin-nonproducing strains were isolated, the lesion
was active when last seen in one patient (this patient was lost
to follow-up) while the keratitis worsened slowly over a 3-
month  period  resulting  in  corneal  perforation  and  finally
healing in the other patient. In the case of eight patients from
whom  toxin-producing  strains  were  isolated,  there  was
complete healing and recovery of visual acuity in one patient
and rapid worsening of the keratitis in four patients (resulting
in  therapeutic  keratoplasty  in  two),  with  the  other  three
patients  being  lost  to  follow-up.  Composite  information
regarding  different  characteristics  of  the  20  (clinical  and
environmental) strains of A. flavus strains used in the study is
provided in Table 3.
During gel electrophoresis of the amplified products, no
significant differences in the length of the amplicons (350 bp)
were observed among the fungal strains (Figure 2). The ITS2
region  sequences  of  the  study  strains  were  compared  by
BLAST analysis with those of selected reference strains of A.
flavus (ATCC 11497, NRRL 4998, NRRL 4822; NRRL 458,
NRRL 3751, NRRL 3518, and NRRL2097); all the study
strains exhibited 100% identity with the molecular siblings.
Less  than  91%  similarity  was  seen  when  comparing  the
sequences of the study strains to those of other Aspergillus
species, except that of Aspergillus oryzae, which revealed a
sequence similarity of 99%. DNA sequence alignments of the
study strains against the sequences of other selected non-
Aspergillus  pathogenic  fungi  in  the  GenBank  database
revealed marked variability. Finally, the sequences of the
study strains were subjected to Blastn in GenBank; the results
obtained were similar to those obtained in the preceding steps.
The assigned sequence accession numbers are listed in Table
1.
Aflatoxin (only B1) was detected by TLC (Figure 3) in
16  (80%)  of  20  samples  (culture  filtrate  or  mycelial
homogenate) of the clinical strains and in eight (40%) of 20
samples  of  the  environmental  strains  (Table  2;  χ2=6.667;
p=0.0098). The mean quantum of aflatoxin B1 detected in the
samples of the clinical strains (366.7±125.4 ppb) was higher
than that detected in the samples of the environmental strains
(306.5±69.1  ppb),  but  this  difference  was  not  statistically
significant.
A significantly higher (χ2=5.051; p=0.0246) proportion
of clinical (70%) than environmental (20%) isolates produced
sclerotia in culture (Figure 4A,B), the size of the sclerotia
exceeding 400 μm in all instances (indicating that the isolates
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848producing sclerotia were all `L’ types). Nine (75%) of the 12
aflatoxin-producing clinical or environmental isolates formed
sclerotia in culture compared to none of the eight aflatoxin-
nonproducing strains (χ2=10.909; p=0.0009).
Seventy percent of the clinical isolates and 50% of the
environmental  isolates  produced  a  beige  ring  in  culture
(Figure  5A,B).  Eleven  (92%)  of  12  aflatoxin-producing
clinical or environmental strains and one (12.5%) of eight
aflatoxin-non producing strains formed a beige ring in culture
(χ2=13.0; p<0.001).
DISCUSSION
Weakening of specific immunological and non-specific host
defenses  may  predispose  to  Aspergillus  infections  in
debilitated and immunocompromised patients in hospitals.
Thermotolerance,  the  ability  to  grow  in  anaerobic
environments and the ability to produce certain proteolytic
enzymes, such as elastases, are putative virulence factors that
allow fungi to elude specific host defenses [37-41]. However,
other factors need to be elucidated.
Aflatoxins  are  secondary  metabolites  produced  by
members of the Aspergillus flavus complex, principally A.
flavus and A. parasiticus [1], and cause illness and disease in
poultry and domestic animals [41]. However, little is known
about production of aflatoxins by clinical isolates of A. flavus
(strains isolated from lesions in humans). This is an aspect that
requires  investigation  because  of  possible  therapeutic
Figure 2. Gel picture showing the PCR amplified product (350 bp)
of the three isolates of Aspergillus flavus. Internal transcribed spacer
2 was used as a target region for DNA amplification. The lane L1
was loaded with 100 bp DNA Ladder; the lanes L2, L3, L4, L5 were
loaded with 10 μl of the amplified product from the test strains C1,
C2, E1, E2, respectively, in 1.5% agarose gels. Lane L6 was loaded
with a negative control to rule out false-positive results.
implications. If an A. flavus strain isolated from a human
lesion is found to possess aflatoxin-producing ability, it may
be  necessary  to  treat  the  lesion  with  not  only  standard
antifungal therapy, which act only on the fungus, but also with
molecules  that  suppress  the  production,  or  neutralize  the
deleterious effects, of aflatoxins.
We  identified  the  clinical  and  environmental  fungal
strains used in the present study by both morphological and
Figure 3. Thin layer chromatograms of culture filtrates of two clinical
and one environmental isolate of Aspergillus flavus. L1: aflatoxin B1
was not detected in the extract from the culture filatrate of test strain
C2 (aflatoxin-non producing clinical strain). L2: aflatoxin B1 was
detected in the extract from the culture filtrate of test strain C1
(aflatoxin-producing clinical strain). L3: aflatoxin B1 was detected
in the extract from the culture filtrate of the test strain E1 (aflatoxin-
producing  environmental  strain).  L4:  aflatoxin  B1  standard  was
loaded for confirmation.
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849molecular methods, since molecular approaches provide more
rapid  and  objective  identification  than  do  traditional
phenotypic methods. Constituents of the ITS region have been
used as targets to identify species, because they generally
display sequence variation between species, but only minor,
or no, variation within strains of the same species [32,42-45].
We  targeted  the  ITS2  region  for  amplification  and  direct
sequencing.  Direct  sequencing,  followed  by  comparative
GenBank analysis, is considered to be one of the most reliable
methods for the identification of species [32,43]. We used
comparative GenBank analysis to confirm that the clinical and
environmental strains were, in fact, A. flavus strains. Several
targets for the molecular identification of aspergilli have been
investigated  in  other  studies  including  the  mitochondrial
cytochrome  b  gene  [46],  a  putative  aflatoxin  pathway
regulatory gene (aflR), the DNA topoisomerase gene [47], the
β-tubulin gene [45] and various rRNA gene regions [32]. But
the most reliable target investigated is ITS region [32], and
hence  we  selected  the  ITS2  region  as  the  target  for  the
molecular identification of the fungal isolates.
A. flavus is the second most frequent cause of invasive
aspergillosis [1,4] and has also emerged as a predominant
pathogen in patients with fungal sinusitis and fungal keratitis
in  several  institutions  worldwide  [6-8,48].  Conidia  in  the
environment  serve  as  the  major  source  of  inoculum  for
Aspergillus  species  (including  A.  flavus)  that  cause
opportunistic  infections  in  plants  and  animals,  including
humans [49]. Kosalec and Pepeljnjak [50] detected aflatoxin
B1 in seven (23%) and aflatoxin G1 in one (3%) of 30 clinical
isolates of A. flavus (from immunocompromised patients in a
hematological unit), and also detected aflatoxins B1 and G1
in 11 (37%) and one (3%) of 30 environmental isolates of A.
flavus. Considering this, in the present study, the isolates from
the cornea and the environment should have exhibited roughly
equal  frequencies  of  aflatoxin  production;  instead,  we
observed that aflatoxin B1 was detected in 80% of culture
filtrate or mycelial homogenate samples of clinical A. flavus
strains, but in only 40% of such samples of environmental A.
flavus strains (Table 1). Production of aflatoxin in vitro by
strains of A. flavus isolated from patients with keratitis has not
previously been reported.
The external environment is the natural habitat of  A.
flavus;  therefore,  A.  flavus  strains  causing  keratitis  by
infecting the cornea would be in an abnormal setting. In such
a  situation,  the  observed  high  frequency  of  aflatoxin
production by the clinical A. flavus strains in the present study
possibly  represented  a  response  to  pressures  (antifungal
chemotherapy, toxic factors released from corneal epithelial
cells, or infiltrating inflammatory cells) that are not conducive
to an ideal existence. A completely contradictory explanation
is  that  the  corneal  tissue,  taken  as  a  whole,  is  actually
conducive to aflatoxin biosynthesis by infecting A. flavus
strains; for example, the normal corneal temperature of 33 °C
to 34 °C [51,52] may stimulate synthesis of aflatoxin. In this
context, it is interesting to note that in two different studies
[13,53], the optimal temperature for aflatoxin production by
A. flavus was found to be 30 °C, with no toxin production at
10 °C [54] or at 20 °C and 37 °C [13,53]; in addition, a
complex interaction of temperature, water activity, incubation
period, and substrate has been found to influence the relative
concentrations of aflatoxins produced by A. flavus [13].
Thus, in the present study, the infected corneal tissue
possibly provided either an unfavorable setting or a favorable
setting for growth of A. flavus, the end-result in either case
being activation of regulatory fungal genes such as aflR and
aflJ which are now considered to be involved in the regulation
of aflatoxin production [55-57]; this effect possibly persisted
even after the fungus was isolated in culture from corneal
scrape material, and subcultured one more time to culture
media.  Interestingly,  structural  genes,  such  as  pksA  and
norA, are also considered to play an important role in aflatoxin
production; deletion of these genes may lead to complete
cessation of aflatoxin production [55].These hypotheses need
to be confirmed by a) detection of aflatoxin in corneal tissue
infected by aflatoxin-producing strains of A. flavus and b)
demonstrating an activation of the fungal genes governing
Figure  4.  Seven  day-old  growth  of  a
clinical isolate of Aspergillus flavus on
Czapek-Dox agar incubated at 30 °C.
A: Formation of sclerotia is noted in the
culture (arrows in inset). Formation of
sclerotia was noted significantly more
frequently  in  aflatoxin-producing
strains than in aflatoxin-nonproducing
strains.  B:  Seven  day-old  growth  of
another  clinical  isolate  of  Aspergillus
flavus on Czapek-Dox agar incubated
30  °C.  This  isolate  has  not  formed
sclerotia in culture.
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850aflatoxin  biosynthesis  upon  transferring  aflatoxin-non
producing strains of A. flavus from the natural environment to
corneal tissue. These aspects will form the basis of future
studies.
When we analyzed the salient information regarding the
10 patients with keratitis from whom strains of A. flavus were
isolated,  we  were  unable  to  discern  definite  patterns  to
correlate  aflatoxin  production  by  the  A.  flavus  strain  and
outcome of therapy. Thus, a larger series of patients probably
needs to be examined. However, it was interesting to note that
the corneal ulceration tended to be moderate in size to total
corneal ulcers in six of the eight patients from whom toxin-
producing  strains  were  isolated.  Toxin  production  by  the
fungal  strain  may  have  contributed  to  the  severity  of  the
lesions observed in these six patients, and the consequent poor
response to medical therapy. Mori et al. [58] reported the
production of aflatoxins in vivo and in vitro by the isolates of
A. flavus from the post mortem lung sample from a patient
with systemic aspergillosis and suggested a possible role of
aflatoxins in damaging the immune system through their toxic
effects.
Most asexual Aspergillus species, including A. flavus,
form resistant structures called sclerotia [50] which survive
environmental extremes even over long periods and form
fresh  mycelia  when  conditions  are  favorable,  thus  re-
establishing  the  infection  process.  There  appears  to  be  a
relationship  between  formation  of  sclerotia  and  aflatoxin
production in culture. Strains of A. flavus that form many
small sclerotia in culture (`S’ types) produce both B- and G-
type aflatoxins [59,60], whereas those that form fewer, large
sclerotia in culture (`L’ types) produce only aflatoxin B1
[61]. Bennet et al. [62] found no correlation between aflatoxin
production and sclerotial production among 14 isolates of A.
flavus  and  A.  parasiticus  whereas  Cotty  [63]  reported  a
positive correlation between high aflatoxin production and
presence of small (<400 μm) sclerotia. In the present study,
nine  (75%)  of  the  12  aflatoxin-producing  (clinical  or
environmental)  strains  of  A.  flavus  and  none  of  the  eight
aflatoxin  nonproducing  strains  formed  sclerotia  in  culture
(p=0.0009).  Our  observations  thus  suggest  that  there  is  a
definite  relationship  between  formation  of  sclerotia  and
production  of  aflatoxin  by  A.  flavus,  and  that  sclerotia
formation may be a reliable marker of aflatoxin production by
an A. flavus strain.
Aflatoxin-producing strains of A. flavus have also been
reported to form a yellow pigment in culture [64-66]. In the
present study, 92% of the aflatoxin-producing (clinical and
environmental)  strains  and  only  12.5%  of  the  aflatoxin-
nonproducing strains of A. flavus were found to form a beige
ring  in  culture  (p=0.0003).  These  results  suggest  that  the
presence of a beige ring (visible to the naked eye under natural
light) surrounding colonies of an A. flavus strain in YESD
medium  may  serve  as  a  marker  of  aflatoxin-producing
potential.
In conclusion, the results of the present study suggest that
aflatoxin production occurs significantly more frequently in
strains of A. flavus isolated from patients with keratitis than it
does in strains of A. flavus isolated from the environment. The
reasons for this phenomenon are unclear and require further
investigation; possibly, the corneal tissue provides either an
unfavorable or a favorable setting for growth of A. flavus, the
end-  result  in  either  case  being  a  stimulus  for  aflatoxin
Figure 5. Three day-old growth of the
isolate  of  Aspergillus  flavus  on  yeast
extract sucrose agar (supplemented with
methyl  β-cyclodextrin  and  sodium
desoxycholate), incubated at 30 °C. A:
Three  day-old  growth  of  a  clinical
isolate  of  Aspergillus  flavus  on  yeast
extract sucrose agar (supplemented with
methyl  β-cyclodextrin  and  sodium
desoxycholate), incubated at 30 °C. A
beige ring (arrow) has formed around
the colony. Formation of a beige ring
was noted significantly more frequently
in  aflatoxin-producing  strains  than  in
aflatoxin-nonproducing  strains.  B:
Three  day-old  growth  of  an
environmental  isolate  of  Aspergillus
flavus  on  yeast  extract  sucrose  agar
supplemented  with  methyl  β-
cyclodextrin  and  sodium
desoxycholate),  incubated  at  30  °C.
There is no beige ring around the colony
growth.
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851production.  This  observation  has  therapeutic  implications,
since it may be necessary to treat patients having keratitis due
to  A.  flavus  with  molecules  that  suppress  production,  or
neutralize the deleterious effects, of aflatoxins. Formation of
sclerotia in CDA and of a beige ring in YESD medium by a
strain of A. flavus may serve as markers of its aflatoxin-
forming potential. The potential to produce aflatoxin may
contribute to the severity of corneal lesions caused by strains
of Aspergillus flavus.
ACKNOWLEDGMENTS
Instrumentation  facility  provided  by  University  Grants
Commision- Special Assistance Programme (UGC-SAP) of
the department of Animal Science, Bharathidasan University
is acknowledged.  A UGC-SAP  Research  Fellowdhip to the
REFERENCES
1. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning
DW.  Aspergillus  flavus:  human  pathogen,  allergen  and
mycotoxin  producer.  Microbiology  2007;  153:1677-92.
[PMID: 17526826]
2. Denning  DW.  Invasive  aspergillosis.  Clin  Infect  Dis  1998;
26:781-803. [PMID: 9564455]
3. Morgan  J,  Wannemuehler  KA,  Marr  KA,  Hadley  S,
Kontoyiannis  DP,  Walsh  TJ,  Fridkin  SK,  Pappas  PG,
Warnock DW. Incidence of invasive aspergillosis following
hematopoietic  stem  cell  and  solid  organ  transplantation:
interim  results  of  a  prospective  multicenter  surveillance
program. Med Mycol 2005; 43:S49-58. [PMID: 16110792]
4. Krishnan  S,  Manavathu  EK,  Chandrasekar  PH.  Aspergillus
flavus:  an  emerging  non-fumigatus  Aspergillus  species  of
significance. Mycoses 2009; 52:206-22. [PMID: 19207851]
5. Thomas  PA.  Fungal  infections  of  the  cornea.  Eye  2003;
17:852-62. [PMID: 14631389]
6. Thomas PA, Kalavathy CM, Rajasekaran J. Microbial keratitis:
a study of 774 cases and review of the literature. Journal of
the Madras State Ophthalmic Association 1986; 23:13-21.
7. Khairallah SH, Byrne KA, Tabbara KF. Fungal keratitis in
Saudi  Arabia.  Doc  Ophthalmol  1992;  79:269-76.  [PMID:
1600844]
8. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal
susceptibility for common pathogens of fungal keratitis in
Shandong  Province,  China.  Am  J  Ophthalmol  2008;
146:260-5. [PMID: 18547535]
9. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev 2003;
16:497-516. [PMID: 12857779]
10. Bennett JW, Christensen SB. New perspectives on aflatoxin
biosynthesis. Adv Appl Microbiol 1983; 29:53-92. [PMID:
6650265]
11. Shih  CH,  Marth  EH.  Some  cultural  conditions  that  control
biosynthesis of lipid and aflatoxin by Aspergillus parasiticus.
Appl Microbiol 1974; 27:452-6. [PMID: 4824880]
12. Northolt MD, Verhulsdonk CAH, Soentoro PSS, Paulsch WE.
Effect  of  water  activity  and  temperature  on  aflatoxin
production by Aspergillus parasiticus. J Milk Food Technol
1976; 39:170-4.
13. Gqaleni  N,  Smith  JE,  Lacey  J,  Gettinby  G.  Effects  of
temperature  and  water  activity,  and  incubation  time  on
production of aflatoxins and cyclopiazonic acid by an isolate
of Aspergillus flavus in surface agar culture. Appl Environ
Microbiol 1997; 63:1048-53. [PMID: 16535539]
14. Buchanan RL Jr, Ayres JC. Effect of initial pH on aflatoxin
production. Appl Microbiol 1975; 30:1050-1. [PMID: 2104]
15. Cotty PJ. Aflatoxin and sclerotial production by Aspergillus
flavus: influence of pH. Phytopathology 1988; 78:1250-3.
16. Keller NP, Nesbitt C, Sar B, Phillips TD, Burrow GB. pH
regulation of sterigmatocystin and aflatoxin biosynthesis in
Aspergillus  spp.  Phytopathology  1997;  87:643-8.  [PMID:
18945083]
17. Hara  S,  Murakami  H,  Ohba  T,  Sugama  S.  Studies  on  the
mycological  characters  of  aflatoxin-producing  strains
belonging to the A. flavus group. E. Production of moldy rice
containing  aflatoxin  from  rice  and  saki  brewing  with  the
moldy rice. Rep Res Inst Brew 1973; 145:13-8.
18. Thapar GS. Metabolite behaviour of aflatoxin producing strain
and  nontoxigenic  strain  of  Aspergillus  flavus  to  different
sources  of  nitrogen  and  glucose  concentration.
Mycopathologia 1988; 102:9-12. [PMID: 3138542]
19. Moss MO, Badii F, Clifford MN. Reduced aflatoxin production
by  Aspergillus  parasiticus  after  growth  on  a  caffeine-
containing medium. Lett Appl Microbiol 1990; 10:205-7.
20. Stollof L. Aflatoxin – an overview. In: Rodrigues JV, Hesseltine
CW, Mehlman M, editors. Mycotoxins in Human and Animal
Health, Park Forest Sout, IL: Pathotox Publishers; 1977. p. 7–
28.
21. Eaton  DL,  Gallagher  EP.  Mechanisms  of  aflatoxin
carcinogenesis.  Annu  Rev  Pharmacol  Toxicol  1994;
34:135-72. [PMID: 8042848]
22. Arora RG, Appelgren LE, Bergman A. Distribution of [14C]-
labelled  aflatoxin  B1  in  mice.  Acta  Pharmacol  Toxicol
(Copenh) 1978; 43:273-9. [PMID: 716944]
23. Larsson P, Larsson BS, Tjälve H. Binding of aflatoxin B1 to
melanin.  Food  Chem  Toxicol  1988;  26:579-86.  [PMID:
3141255]
24. Larsson P, Ngethe S, Ingebrigtsen K, Tjälve H. Extrahepatic
disposition  of  3H-aflatoxin  B1  in  the  rainbow  trout
(Oncorhynchus  mykiss).  Pharmacol  Toxicol  1992;
71:262-71. [PMID: 1454751]
25. Larsson  P,  Busk  L,  Tjälve  H.  Hepatic  and  extrahepatic
bioactivation and GSH conjugation of aflatoxin B1 in sheep.
Carcinogenesis 1994; 15:947-55. [PMID: 8200100]
26. Larsson P, Tjälve H. Bioactivation of aflatoxin B1 in the nasal
and  tracheal  mucosa  in  swine.  J  Anim  Sci  1996;
74:1672-80. [PMID: 8818814]
27. Cilievici O, Cordos I, Ghiduş E, Moldovan A. The toxic and
teratogenic  effect  of  aflatoxin  B1  on  the  chick  embryo
development. Morphol Embryol (Bucur) 1980; 26:309-14.
[PMID: 6450879]
28. Kant S, Srivastava D, Misra RN. Toxic effects of aflatoxins on
eyes-an  experimental  clinic-histopahtological  evaluation.
Indian J Ophthalmol 1984; 32:424-6. [PMID: 6443611]
29. Thomas PA, Leck AK, Myatt M. Characteristic clinical features
as an aid to the diagnosis of suppurative keratitis caused by
filamentous fungi. Br J Ophthalmol 2005; 89:1554-8. [PMID:
16299128]
30. Senior  BW.  Examination  of  water,  milk,  food  and  air.  In:
Mackie  &  McCartney,  editors.  Practical  Medical
Microbiology.  NewYork:  Churchill  livingstone;  1996.  p.
883–921.
Molecular Vision 2010; 16:843-854 <http://www.molvis.org/molvis/v16/a94> © 2010 Molecular Vision
852
first author is gratefully acknowledged.31. Kumar  M,  Mishra  NK,  Shukla  PK.  Sensitive  and  rapid
polymerase  chain  reaction  based  diagnosis  of  mycotic
keratitis  through  single  stranded  conformation
polymorphism. Am J Ophthalmol 2005; 140:851-7. [PMID:
16310463]
32. Hinrikson HP, Hurst SF, Lott TJ, Warnock DW, Morrison CJ.
Assessment  of  Ribosomal  large-subunit  D1–D2,  internal
transcribed spacer 1 and internal transcribed spacer regions
as targets for molecular identification of medically important
Aspergillus  species.  J  Clin  Microbiol  2005;  43:2092-103.
[PMID: 15872227]
33. Pryzybylski W. Formation of aflatoxin derivatives on thin layer
chromatographic  plate.  J  Assoc  Of  Anal  Chem  1975;
58:163-4. [PMID: 1141149]
34. Nabney  J,  Nesbitt  BF.  A  spectrophotometric  method  for
determining the aflatoxins. Analyst (Lond) 1965; 90:155-60.
35. Jaimez Ordaz J, Fente CA, Vázquez BI, Franco CM, Cepeda A.
Development of a method for direct visual determination of
aflatoxin production by colonies of the Aspergillus flavus
group.  Int  J  Food  Microbiol  2003;  83:219-25.  [PMID:
12706042]
36. http://www.quantitativeskills.com/sisa/statistics/
twoby2.htmhttp://www.quantitativeskills.com/sisa/statistics/
twoby2.htm
37. Kothary MH, Chase T Jr, MacMillan JD. Correlation of elastase
production by some strains of Aspergillus fumigatus with
ability to cause invasive aspergillosis in mice. Infect Immun
1984; 43:320-5. [PMID: 6360904]
38. Rippon  JW.  The  Pathogenic  Fungi  and  the  Pathogenic
Actinomycetes.  Medical  Mycology:  3rd  ed.  Philadelphia:
WB Saunders; 1988.
39. Hogan LH, Klein BS, Levitz SM. Virulence factors of medically
important fungi. Clin Microbiol Rev 1996; 9:469-88. [PMID:
8894347]
40. Bhabhra  R,  Askew  DS.  Thermotolerance  and  virulence  of
Aspergillus  fumigatus:  role  of  the  fungal  nucleolus.  Med
Mycol 2005; 43:S87-93. [PMID: 16110798]
41. Bondy GS, Pestlea JJ. Immunomodulation by fungal toxin. J
Toxicol Envirn Health B Crit Rev 2000; 3:109-43. [PMID:
10834078]
42. Shin  JH,  Nolte  FS,  Morrison  CJ.  Rapid  identification  of
Candida species in blood cultures by a clinically useful PCR
method. J Clin Microbiol 1997; 35:1454-9. [PMID: 9163461]
43. Henry T, Iwen PC, Hinrichs SH. Identification of Aspergillus
species using Internal Transcribed Spacer region 1 and 2. J
Clin Microbiol 2000; 38:1510-5. [PMID: 10747135]
44. Iwen PC, Hinrichs SH, Rupp ME. Utilization of the internal
transcribed spacer regions as molecular targets to detect and
identify  human  fungal  pathogens.  Med  Mycol  2002;
40:87-109. [PMID: 11860017]
45. Balajee  SA,  Kano  R,  Baddley  JW,  Moser  SA,  Marr  KA,
Alexander  BD,  Andes  D,  Kontoyiannis  DP,  Perrone  G,
Peterson  S,  Brandt  ME,  Pappas  G,  Chiller  T.  Molecular
identification  of  Aspergillus  species  collected  from  the
transplant-associated infection surveillance network. J Clin
Microbiol 2009; 47:3138-41. [PMID: 19675215]
46. Yokojama  K,  Wang  L,  Takahasi  H,  Kase  N,  Miyaj  M,
Nishimura K. Molecular typing of Aspergillus setion Flavi by
mitochondrial cytochrome b gene analysis. J Japanese Assoc
Mycotoxicol 1999; 49:27-33.
47. Kanbe T, Arishima T, Horii T, Kikuchi A. Improvement of
PCR-based identification targeting the DNA topoisomerase
II gene to determine major species of the opportunistic fungi
Candida  and  Aspergillus  fumigatus.  Microbiol  Immunol
2003; 47:631-8. [PMID: 14584610]
48. Xess  I,  Mohanty  S,  Jain  N,  Banerjee  U.  Prevalence  of
Aspergillus species in clinical samples isolated in an Indian
tertiary  care  hospital.  Indian  J  Med  Sci  2004;  58:513-9.
[PMID: 15627677]
49. Calvo  AM,  Wilson  RA,  Bok  JW,  Keller  NP.  Relationship
between  secondary  metabolism  and  fungal  development.
Microbiol Mol Biol Rev 2002; 66:447-59. [PMID: 12208999]
50. Kosalec  I,  Pepeljnjak  S.  Mycotoxigenicity  of  clinical  and
environmental Aspergillus fumigatus and A.flavus isolates.
Acta Pharm 2005; 55:365-75. [PMID: 16375826]
51. Fujishima H, Toda I, Yamada M, Sato N, Tsuboth K. Corneal
temperature in patients with dry eye evaluated by infrared
radiation  thermometry.  Br  J  Ophthalmol  1996;  80:29-32.
[PMID: 8664227]
52. Shiloh R, Portuguese S, Bodinger L, Katz N, Sigler M, Hermesh
H, Munitz H, Weizman A. Increased corneal temperature in
drug-free  male  schizophrenia  patients.  Eur
Neuropsychopharmacol 2003; 13:49-52. [PMID: 12480122]
53. Ogundero  VW.  Temperature  and  aflatoxin  production  by
Aspergillus flavus and A. parasiticus strains from Nigerian
groundnuts.  J  Basic  Microbiol  1987;  27:511-4.  [PMID:
3136240]
54. Burow GB, Nesbitt TC, Dunlap J, Keller NP. Seed lipoxygenase
products modulate Aspergillus mycotoxin biosynthesis. Mol
Plant Microbe Interact 1997; 10:380-7.
55. Bhatnagar D, Ehrlich KC, Cleveland TE. Molecular genetic
analysis  and  regulation  of  aflatoxin  biosynthesis.  Appl
Microbiol Biotechnol 2003; 61:83-93. [PMID: 12655449]
56. Yu JH, Butchko RAE, Fernandes M, Keller NP, Leonard T,
Adams TH. Conservation of structure and function of the
aflatoxin regulatory gene aflR from Aspergillus nidulans and
A. flavus. Curr Genet 1996; 29:549-55. [PMID: 8662194]
57. Meyers  DM,  Obrian  G,  Du  WL,  Bhatnagar  D,  Payne  GA.
Characterization of aflJ, a gene required for conversion of
pathway intermediates to aflatoxin. Appl Environ Microbiol
1998; 64:3713-7. [PMID: 9758789]
58. Mori T, Matsumura M, Yamada K, Irie S, Oshimik S, Oguri T,
Ichinoe M. Systemic aspergillosis caused by and aflatoxin-
producing strain of Aspergillus flavus. Med Mycol 1998;
36:107-12. [PMID: 9776821]
59. Hesseltine CW, Shotwell O, Smith M, Ellis JJ, Vandegraft E,
Shannon G. Production of various aflatoxins by strains of
Aspergillus flavus series. In Herzberg M, editors. Proceedings
of the first U.S Japan conference on toxic microorganisms.
Washington: Government printing office. 1970. p. 202–10.
60. Saito  M,  Tsuruta  O,  Siriacha  P,  Kawasugi  S,  Manabe  M.
Atypical strains of Aspergillus flavus isolated in maize fields.
Jpn Agric Res Q 1989; 23:151-4.
61. Singh K, Frisvad JC, Thrane U, Mathur SB. An illustrated
manual  on  identification  of  some  seed-borne  Aspergilli,
Fusaria, Penicillia and their mycotoxins. Danish government
of  See  pathology  for  developing  countries,  Hellerup,
Denmark. 1991.
62. Bennett JW, Horowitz PC, Lee LS. Production of sclerotia by
aflatoxigenic  and  non-aflatoxigenic  strains  of  Aspergillus
Molecular Vision 2010; 16:843-854 <http://www.molvis.org/molvis/v16/a94> © 2010 Molecular Vision
853flavus  and  Aspergillus  parasiticus.  Mycologia  1979;
71:415-22. [PMID: 114828]
63. Cotty  PJ.  Virulence  and  cultural  characteristics  of  two
Aspergillus  flavus  strains  pathogenic  on  cotton.
Phytopathology 1989; 79:808-14.
64. Wiseman HG, Jacobson WC, Harmeyer WC. Note on removal
of pigments from chloroform extracts of aflatoxic cultures
with copper carbonate. Journal of the Association of Official
Agricultural Chemists 1967; 50:982-3.
65. Bothast RJ, Fennell DI. A medium for rapid identification and
enumeration  of  Aspergillus  flavus  and  related  organisms.
Mycologia 1974; 66:365-9. [PMID: 4208153]
66. Lin  MT,  Dianese  JC.  A  coconut-agar  medium  for  rapid
detection  of  aflatoxin  production  by  Aspergillus  spp.
Phytopathology 1976; 66:1466-9.
Molecular Vision 2010; 16:843-854 <http://www.molvis.org/molvis/v16/a94> © 2010 Molecular Vision
The print version of this article was created on 7 May 2010. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
854